Endoscopic findings and outcomes of gastric mucosal changes relating to potassium‐competitive acid blocker and proton pump inhibitor therapy
Abstract Gastric mucosal changes associated with long‐term potassium‐competitive acid blocker and proton pump inhibitor (PPI) therapy may raise concern. In contrast to that for PPIs, the evidence concerning the safety of long‐term potassium‐competitive acid blocker use is scant. Vonoprazan (VPZ) is...
Saved in:
| Main Authors: | Satoshi Shinozaki, Hiroyuki Osawa, Yoshimasa Miura, Hiroaki Nomoto, Hirotsugu Sakamoto, Yoshikazu Hayashi, Tomonori Yano, Edward J. Despott, Hironori Yamamoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | DEN Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/deo2.400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
by: Gerson Domingues, et al.
Published: (2022-08-01) -
Profound gastric mucosal changes and severe rebound acid hypersecretion after long‐term Vonoprazan use: A case report
by: Hiroko Suda, et al.
Published: (2025-04-01) -
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
by: Mun Young Cho, et al.
Published: (2023-09-01) -
Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment
by: Peiwen Dong, et al.
Published: (2025-05-01) -
Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers
by: Ryan Herardi, et al.
Published: (2025-07-01)